Snippet Search

Searching 11,767,396 documents.
Discover how a particular term or phrase is used in scientific literature

Showing 1 to 25 of 555 matching articles

Results per page:

... various chemotherapeutic drugs, such as  mitomycin 
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy
Braam, H. J.; Hoogwater, F. J. H.
or cisplatin, are used for HIPEC. ...
... IV (DPPIV) − host rats are pretreated with  mitomycin 
Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat
Late Gestation Fetal Hepatocytes for Liver Repopulation in the Rat
Sanders, Jennifer A.
CMitomycin C to prevent adult hepatocyte ...
... following intraoperative administration of  mitomycin 
Mitomycin
Mitomycin
0.02% [routes, dosages and outcomes not ...
... led to the first reports of HIPEC using  mitomycin 
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution
Mehta, Akash M.; Huitema, Alwin D. R.; Burger, Jacobus W. A.; Brandt-Kerkhof, Alexandra R. M.; Heuvel, Sander F.; Verwaal, Victor J.
C for patients with peritoneal ...
... growth-arrest with the cost-effective  Mitomycin 
An optimization protocol for Swiss 3T3 feeder cell growth-arrest by Mitomycin C dose-to-volume derivation strategy
An optimization protocol for Swiss 3T3 feeder cell growth-arrest by Mitomycin C dose-to-volume derivation strategy
Chugh, Rishi Man; Chaturvedi, Madhusudan; Yerneni, Lakshmana Kumar
C vis-à-vis irradiation is controversial ...
... patients were treated with intraperitoneal  mitomycin 
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution’s Experience During Two Decades
Ihemelandu, Chukwuemeka; Sugarbaker, Paul H.
C and 5-FU during the perioperative ...
... anal margin, ESMO suggests treatment with  Mitomycin 
Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review
Discrepancies between NCCN and ESMO guidelines in the management of anal cancer: a qualitative review
Johnson, Natalie; Pellino, Gianluca; Simillis, Constantinos; Qiu, Shengyang; Nikolaou, Stella; Baird, Daniel L.; Rasheed, Shahnawaz; Tekkis, Paris P.; Kontovounisios, Christos
/5-FU and radiotherapy. ...
... focus on myeloid suppressor cell therapy by  mitomycin 
Cell therapeutic approaches to immunosuppression after clinical kidney transplantation
Cell therapeutic approaches to immunosuppression after clinical kidney transplantation
Morath, Christian; Schmitt, Anita; Kälble, Florian; Zeier, Martin; Schmitt, Michael; Sandra-Petrescu, Flavius; Opelz, Gerhard; Terness, Peter; Schaier, Matthias; Kleist, Christian
C-induced cells (MICs). ...
... and chemotherapy with 5-fluorouracil and  mitomycin 
Long-standing Crohn’s disease and its implication on anal squamous cell cancer management
Long-standing Crohn’s disease and its implication on anal squamous cell cancer management
Lightner, Amy L; Moncrief, Sara B.; Smyrk, Thomas C.; Pemberton, John H.; Haddock, Michael G.; Larson, David W.; Dozois, Eric J.; Mathis, Kellie L.
; one patient received cisplatin rather ...
... Komplikation nach Trabekulektomie mit  Mitomycin 
Frühe Bindehautatrophie nach Trabekulektomie mit Mitomycin-C-Applikation und Kollagen-Matrix-Implantation
Frühe Bindehautatrophie nach Trabekulektomie mit Mitomycin-C-Applikation und Kollagen-Matrix-Implantation
Siggel, R.; Dietlein, T.
-C-Applikation und subkonjunktivaler ...
... region. This DNA demethylation occurred in  mitomycin 
RUNX1 induces DNA replication independent active DNA demethylation at SPI1 regulatory regions
RUNX1 induces DNA replication independent active DNA demethylation at SPI1 regulatory regions
Goyal, Shubham; Suzuki, Takahiro; Li, Jing-Ru; Maeda, Shiori; Kishima, Mami; Nishimura, Hajime; Shimizu, Yuri; Suzuki, Harukazu
-C-treated nonproliferating cells at both ...
... 5 × 103 J/m2, hydrogen peroxide (50 mM) and  mitomycin 
Radio-protective and antioxidative activities of astaxanthin from newly isolated radio-resistant bacterium Deinococcus sp. strain WMA-LM9
Radio-protective and antioxidative activities of astaxanthin from newly isolated radio-resistant bacterium Deinococcus sp. strain WMA-LM9
Sajjad, Wasim; Ahmad, Mazoor; Khan, Salman; Ilyas, Sunniya; Hasan, Fariha; Celik, Cem; McPhail, Kerry; Shah, Aamer Ali
C (10 μg/ml). ...
... developed. One such cytostatic agent is  mitomycin 
Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C
Quality of transurethral resection of bladder tumor procedure influenced a phase III trial comparing the effect of KLH and mitomycin C
Prasad, Narasimha N. G.; Muddukrishna, Shammana N.
C (MM). ...
... received hyperthermic intraperitoneal  mitomycin 
Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites
Treatment of Pseudomyxoma Peritonei from Non-appendiceal Primary Sites
Sugarbaker, Paul H.
C (15 mg/m2) and doxorubicin (15 mg/m2) and ...
... HEPES buffer (Invitrogen # 15630106). 18.  Mitomycin 
Maintenance of Human Embryonic Stem Cells by Sphingosine-1-Phosphate and Platelet-Derived Growth Factor
Maintenance of Human Embryonic Stem Cells by Sphingosine-1-Phosphate and Platelet-Derived Growth Factor
Wong, Raymond C. B.; Pera, Martin F.; Pébay, Alice
C from S. ...
... and top agar from Oxoid (Basingstoke, UK).  Mitomycin 
Two dechlorinated chlordecone derivatives formed by in situ chemical reduction are devoid of genotoxicity and mutagenicity and have lower proangiogenic properties compared to the parent compound
Two dechlorinated chlordecone derivatives formed by in situ chemical reduction are devoid of genotoxicity and mutagenicity and have lower proangiogenic properties compared to the parent compound
Legeay, Samuel; Billat, Pierre-André; Clere, Nicolas; Nesslany, Fabrice; Bristeau, Sébastien; Faure, Sébastien; Mouvet, Christophe
C (CAS Registry Number: 50–07-7), ...
... (PIC) with cisplatin, fluorouracil,  mitomycin 
Antineoplastics
Antineoplastics
[ ...
... with or without corticosteroids and  Mitomycin 
Idiopathic subglottic stenosis: an epidemiological single-center study
Idiopathic subglottic stenosis: an epidemiological single-center study
Aarnæs, Maria Tyse; Sandvik, Leiv; Brøndbo, Kjell
C, with dilatation by balloon or bougie. ...
... infection while receiving treatment with  mitomycin 
Mitomycin
Mitomycin
[ ...
... 1 (3.1) 0 (0.0) NS  Cisplatin/  mitomycin 
Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
Whealon, Matthew D.; Gahagan, John V.; Sujatha-Bhaskar, Sarath; O’Leary, Michael P.; Selleck, Matthew; Dumitra, Sinziana; Lee, Byrne; Senthil, Maheswari; Pigazzi, Alessio
C 0 (0.0) 1 (2.4) NS   ...
... To assess the role of topically applied  Mitomycin 
Role of Topical Medication in Prevention of Post-extubation Subglottic Stenosis
Role of Topical Medication in Prevention of Post-extubation Subglottic Stenosis
Prasanna Kumar, Saravanam; Ravikumar, Arunachalam; Thanka, Johnson
-C and Triamcinolone Acetonide in wound ...
... observation that the combination of 5-FU,  mitomycin 
Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents
Therapeutic Ratio of Reirradiation with Cytotoxic Drugs and Other Response-Modifying Agents
Nieder, Carsten; Eisbruch, Avraham
C, or cisplatin with radiation is of value ...
... line, Jurkat, with MT-2 cells treated with  mitomycin 
Infection of defective human T-lymphotropic virus type 1
Infection of defective human T-lymphotropic virus type 1
Hashikura, Yuuki; Umeki, Kazumi; Umekita, Kunihiko; Nomura, Hajime; Yamada, Akiteru; Yamamoto, Ikuo; Hasegawa, Hiroo; Yanagihara, Katsunori; Okayama, Akihiko
C. ...
... Background  Mitomycin 
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration
Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration
Myers, Alan L.; Zhang, Yan-Ping; Kawedia, Jitesh D.; Zhou, Ximin; Sobocinski, Stacey M.; Metcalfe, Michael J.; Kramer, Mark A.; Dinney, Colin P. N.; Kamat, Ashish M.
C (MMC) is an antitumor agent that is often ...
... CTx chemotherapy, 5-FU 5-fluorouracil, MMC  mitomycin 
Radiation Therapy
Radiation Therapy
Choi, Jinhyun; Seong, Jinsil
-C Selected Studies of Neoadjuvant ...